Valsts: Īrija
Valoda: angļu
Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)
Ibuprofen
Reckitt Benckiser Ireland Ltd
M01AE; M01AE01
Ibuprofen
200 milligram(s)
Coated tablet
Product not subject to medical prescription
Propionic acid derivatives; ibuprofen
Marketed
2011-05-27
NUROFEN EXPRESS 200MG TABLETS Ibuprofen (as sodium dihydrate) PACKAGE LEAFLET: INFORMATION FOR THE USER READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. This medicine is available without prescription. However, you still need to take Nurofen Express 200mg Tablets carefully to get the best results from it. • Keep this leaflet. You may need to read it again. • Ask your pharmacist if you need more information or advice. • You must contact a doctor if your symptoms worsen or do not improve after 3 days. • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET 1 What Nurofen Express 200mg Tablets are and what they are used for 2 Before you take Nurofen Express 200mg Tablets 3 How to take Nurofen Express 200mg Tablets 4 Possible side effects 5 How to store Nurofen Express 200mg Tablets 6 Further information 1. WHAT NUROFEN EXPRESS 200MG TABLETS ARE AND WHAT ARE THEY USED FOR: The active ingredient (which makes the medicine work) in Nurofen Express 200mg Tablets is ibuprofen 200 mg (as sodium dihydrate 256mg). Ibuprofen belongs to a group of medicines called Non-Steroidal Anti- Inflammatory Drugs (NSAIDs). These medicines work by changing how the body responds to pain, swelling and high temperature. Nurofen Express 200mg Tablets are used for the relief of fever and mild to moderate pain such as: • headaches, period pain, and dental pain • muscle pain and backache • symptoms of colds and flu, and high temperature (fever) 2.BEFORE YOU TAKE NUROFEN EXPRESS 200MG TABLETS Do not take these tablets if you: • are allergic (hypersensitive) to ibuprofen or any of the other ingredients (see Section 6: Further Information) • are allergic (hypersensitive) to aspirin or to other painkillers • have or ever had a stomach ulcer, perforation or bleeding in the stomach • have ever had gastrointestinal bleeding in relation to NSAID therapy • have severe liver or kidney problems Izlasiet visu dokumentu
Health Products Regulatory Authority 22 May 2023 CRN00DDJT Page 1 of 9 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Nurofen Express 200 mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains Ibuprofen 200mg (as sodium dihydrate) Excipients with known effect: Each tablet contains Sodium: 27.94mg (1.21mmol) of sodium per tablet. Sucrose: 93.1mg per tablet. For a full list of excipients, see Section 6.1. 3 PHARMACEUTICAL FORM Coated Tablet. A white to off-white, biconvex, round, sugar coated tablet with an identifying logo in black on one face. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS As an anti-inflammatory, analgesic and antipyretic for short-term management of mild to moderate pain such as is associated with headache, dental pain, fever, period pain, muscular strain, backache, and for the management of the symptoms of head colds and influenza. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For oral administration and short term use only. The lowest effective dose should be used for the shortest duration necessary to relieve symptoms (see section 4.4). Adults and children over 12 years: Initial dose is one or two tablets and subsequently if necessary, one or two tablets every four hours with a maximum of 6 tablets in a 24 hour period i.e. a maximum dose of 1200mg in a 24 hour period. If the medicinal product is required for more than 3 days or if the symptoms worsen, the patient should consult a doctor. If in adolescents this medicinal product is required for more than 3 days, or if symptoms worsen a doctor should be consulted. Not suitable for children under 12 years of age without medical advice NSAIDs should be used with particular caution in elderly patients who are more prone to adverse events. The lowest dose compatible with adequate safe clinical control should be employed please refer to section 4.4. Treatment should be reviewed at regular intervals and discontinued if no benefit is seen or intolerance occurs. 4.3 CONTRAINDICATIONS History of gastrointestinal Izlasiet visu dokumentu